Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Non-interventional Retrospective Cohort Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection

NCT05196477 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT05196477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05196477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Non-interventional Retrospective Cohort Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection
Lead sponsor
R-Pharm
Phase
Observational
Overall status
Completed
Start date
July 14, 2021
Completion date
August 29, 2022
Enrollment
3,087 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19